Overview
Dr. Mothaffar F. Rimawi is a board-certified medical oncologist specializing in breast cancer care and research. He is Professor at the Department of Medicine, Section of Hematology and Oncology at Baylor College of Medicine. Dr. Rimawi is also Executive Medical Director & Associate Director of Clinical Affairs and Co-Leader of the Breast Cancer Program at BCM’s Dan L Duncan Comprehensive Cancer Center. Additionally, he serves as Chief of the Oncology Service Line at St Luke's Health in Houston.Dr. Rimawi’s professional interests include: the diagnosis, treatment and management of breast cancer; clinical trials in breast cancer; neoadjuvant therapy; targeted therapy and biomarkers in breast cancer; treatment resistance to ER and HER2-targeted therapies in breast cancer; locally advanced breast cancer; and breast disease and cancer.Dr. Rimawi received his medical degree from the University of Jordan in Amman, Jordan. He completed his residency in Internal Medicine and fellowships in Medical Oncology and Hematology and Breast Cancer at BCM. Dr. Rimawi holds certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology and the American Medical Association.In addition to English, Dr. Rimawi speaks Arabic.
Dr. Rimawi is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast.
His clinical research consists of co-authoring 108 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6720 Bertner Ave, Houston, TX 77030
2525 A Holly Hall St, Unit 3c, Houston, TX 77054
7200 Cambridge St, Houston, TX 77030
1504 Taub Loop, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
21 Clinical Trials
MD Anderson
Jennifer Litton is an Oncologist in Houston, Texas. Dr. Litton is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.
MD Anderson
Bora Lim is an Oncologist and a Hematologist in Houston, Texas. Dr. Lim is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.
MD Anderson
Clinton Yam is an Oncologist in Houston, Texas. Dr. Yam is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Rimawi isElite. Learn about Breast Cancer.
- HER-2 Positive Breast Cancer
- Distinguished
- Paget Disease of the BreastDr. Rimawi isDistinguished. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Rimawi isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- AngiosarcomaDr. Rimawi isAdvanced. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Rimawi isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Brain TumorDr. Rimawi isExperienced. Learn about Brain Tumor.
- Breast Cancer in MenDr. Rimawi isExperienced. Learn about Breast Cancer in Men.
- Familial Pancreatic CancerDr. Rimawi isExperienced. Learn about Familial Pancreatic Cancer.
- Intraductal PapillomaDr. Rimawi isExperienced. Learn about Intraductal Papilloma.
- Megalencephalic Leukoencephalopathy with Subcortical Cysts
- MenopauseDr. Rimawi isExperienced. Learn about Menopause.